Scarica l'app Stockscreener
5.16
1.34%
-0.07
Dopo l'orario di chiusura:
5.26
0.10
+1.94%
Precedente Chiudi:
$5.23
Aprire:
$5.26
Volume 24 ore:
38,695
Relative Volume:
0.74
Capitalizzazione di mercato:
$48.74M
Reddito:
$5.12M
Utile/perdita netta:
$-67.00M
Rapporto P/E:
-3.5102
EPS:
-1.47
Flusso di cassa netto:
$-38.94M
1 W Prestazione:
-7.03%
1M Prestazione:
-7.36%
6M Prestazione:
-16.96%
1 anno Prestazione:
-77.57%
Intervallo 1D:
$4.91
$5.39
Intervallo di 1 settimana:
$4.91
$5.748
Portata 52W:
$3.816
$23.20
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Nome
Verrica Pharmaceuticals Inc
Settore
Industria
Telefono
484-453-3300
Indirizzo
10 NORTH HIGH STREET, WEST CHESTER, PA
Confronta VRCA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
5.16 | 50.53M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-06 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-07-25 | Aggiornamento | Needham | Hold → Buy |
| 2023-03-22 | Iniziato | Jefferies | Buy |
| 2023-02-13 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-05-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-05-14 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-12-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-24 | Iniziato | Northland Capital | Outperform |
| 2020-03-24 | Iniziato | Needham | Buy |
| 2019-02-21 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Verrica Pharmaceuticals Inc Borsa (VRCA) Ultime notizie
Will Verrica Pharmaceuticals Inc. face regulatory challenges2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - khodrobank.com
What’s the outlook for Verrica Pharmaceuticals Inc.’s sectorInsider Selling & Growth Focused Entry Point Reports - khodrobank.com
RSI + MACD Show Convergence for Verrica Pharmaceuticals Inc.2025 Stock Rankings & Low Drawdown Trading Techniques - beatles.ru
Will Verrica Pharmaceuticals Inc. price bounce be sustainableBear Alert & Daily Market Momentum Tracking - Newser
What MACD and RSI say about Verrica Pharmaceuticals Inc.July 2025 Intraday Action & Free Weekly Watchlist of Top Performers - Newser
Best data tools to analyze Verrica Pharmaceuticals Inc. stockTrend Reversal & Stepwise Trade Execution Plans - Newser
Sector ETF performance correlation with Verrica Pharmaceuticals Inc.July 2025 Decliners & Fast Exit Strategy with Risk Control - Newser
Will Verrica Pharmaceuticals Inc. benefit from macro trendsEarnings Performance Report & Weekly Momentum Stock Picks - Newser
Real time alert setup for Verrica Pharmaceuticals Inc. performance2025 Year in Review & Risk Managed Investment Entry Signals - Newser
Is Verrica Pharmaceuticals Inc. stock reversal real or fake2025 Market Outlook & Weekly High Conviction Ideas - Newser
How moving averages guide Verrica Pharmaceuticals Inc. tradingLayoff News & Accurate Buy Signal Notifications - Newser
What’s the fair value of Verrica Pharmaceuticals Inc. stockJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - khodrobank.com
Can a trend reversal in Verrica Pharmaceuticals Inc. lead to recoveryMarket Movers & Real-Time Chart Breakout Alerts - Newser
Can technical indicators confirm Verrica Pharmaceuticals Inc.’s reversalEarnings Beat & Risk Controlled Stock Alerts - Newser
When is the best time to exit Verrica Pharmaceuticals Inc.M&A Rumor & Risk Managed Investment Entry Signals - Newser
What earnings revisions data tells us about Verrica Pharmaceuticals Inc.July 2025 Reactions & Technical Pattern Alert System - Newser
How high can Verrica Pharmaceuticals Inc. stock go2025 Breakouts & Breakdowns & Real-Time Volume Triggers - Newser
What to expect from Verrica Pharmaceuticals Inc. in the next 30 days2025 Market Outlook & Risk Managed Investment Signals - Newser
Heatmap analysis for Verrica Pharmaceuticals Inc. and competitors2025 Top Gainers & Weekly High Return Stock Forecasts - Newser
Developing predictive dashboards with Verrica Pharmaceuticals Inc. dataBull Run & Accurate Trade Setup Notifications - Newser
What’s the profit margin of Verrica Pharmaceuticals Inc.2025 Investor Takeaways & Technical Pattern Alert System - khodrobank.com
Statistical indicators supporting Verrica Pharmaceuticals Inc.’s strengthJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - Newser
Verrica Pharmaceuticals shares fall 3.84% intraday as CEO to present at H.C. Wainwright conference. - AInvest
What is the Moat Score of Verrica Pharmaceuticals Inc.Trend Reversal & Growth Focused Entry Point Reports - khodrobank.com
How to manage a losing position in Verrica Pharmaceuticals Inc.2025 Valuation Update & Precise Buy Zone Tips - Newser
Volatility clustering patterns for Verrica Pharmaceuticals Inc.Trade Signal Summary & Free Safe Capital Growth Stock Tips - Newser
Applying Elliott Wave Theory to Verrica Pharmaceuticals Inc.July 2025 Breakouts & Verified Chart Pattern Signals - Newser
Verrica Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Has Verrica Pharmaceuticals Inc. found a price floorBond Market & Stepwise Entry/Exit Trade Alerts - Newser
How to integrate Verrica Pharmaceuticals Inc. into portfolio analysis tools2025 Top Gainers & Verified Entry Point Signals - Newser
Dermatology Therapeutics Leader Verrica Pharmaceuticals to Showcase at Major H.C. Wainwright Conference - Stock Titan
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
A | Is Verrica Pharmaceuticals Inc. a stock for growth or value investorsQuarterly Investment Review & AI Based Trade Execution Alerts - khodrobank.com
What is Verrica Pharmaceuticals Inc. s debt to equity ratioJuly 2025 PreEarnings & Weekly Stock Breakout Alerts - khodrobank.com
Order flow analysis tools used on Verrica Pharmaceuticals Inc.Earnings Risk Summary & Daily Technical Forecast Reports - Newser
Is Verrica Pharmaceuticals Inc. benefiting from innovation trendsFed Meeting & Safe Entry Trade Signal Reports - khodrobank.com
Aug Update: Is Verrica Pharmaceuticals Inc. currently under institutional pressureOil Prices & Technical Pattern Alert System - khodrobank.com
Top chart patterns to watch in Verrica Pharmaceuticals Inc.Price Action & Safe Investment Capital Preservation Plans - Newser
Verrica Pharmaceuticals Q2 Earnings Call Highlights Growth, Strategic Partnerships, and Improved Financial Performance, with Record YCANTH Sales and Strategic Partnership Milestone - AInvest
Market Trends: Volume Profile Shows Strong Base for Verrica Pharmaceuticals Inc.July 2025 Review & Stepwise Trade Signal Guides - beatles.ru
Chart based exit strategy for Verrica Pharmaceuticals Inc.Market Volume Summary & Low Drawdown Momentum Trade Ideas - Newser
Verrica Pharmaceuticals Inc Azioni (VRCA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):